Drug recall
Blood and Blood Products for Reprocessing
FDA recall event 82596 · Class II, Class III · New York Blood Center, Inc.
Key facts
| Event ID | 82596 |
|---|---|
| Recall numbers | B-0494-2019, B-0495-2019 |
| Recalling firm | New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Blood and Blood Products for Reprocessing, Red Blood Cells, Leukocytes Reduced |
| Classification | Class II, Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, for which donor eligibility screening was incorrectly performed, were distributed. |
| Initiation date | Mar 28, 2019 |
| Report date | Apr 24, 2019 |
| Termination date | Apr 15, 2019 |
| City | New York |
| State | NY |
| Country | United States |
| FEI number | 2476837 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: